InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: Number sleven post# 279555

Friday, 06/12/2020 7:30:08 AM

Friday, June 12, 2020 7:30:08 AM

Post# of 427377
sleven...

Vascepa is Tier 4 in most drug plans..Tier four is designation for a brand drug for which there exists a cheaper alternative...The cheaper alternative here is Lovaza..The drug plans have ignored the R-I results because the FDA label did not change until late December 2019 and this was after the Tier designations were determined...for 2020...

GV will never be be Tier 1 as long as Lovaza or GL is cheaper..Lovaza has the same label as GV For Indications and Usage...GV or GL neither have the R-I indication and beginning next year Vascepa prescribed for CVD risk reduction will not have any competitors..



":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News